HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

J. Biol. Chem., Vol. 277, Issue 17, 14355-14358, April 26, 2002

This Article Abstract Full Text (PDF) All Versions of this Article: 277/17/14355    most recent C100762200v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ishida, N. Articles by Nakayama, K. I. Search for Related Content PubMed PubMed Citation Articles by Ishida, N. Articles by Nakayama, K. I. Social Bookmarking                      What's this?

ACCELERATED PUBLICATION
Phosphorylation of p27^Kip1 on Serine 10 Is Required for Its Binding to CRM1 and Nuclear Export^*

Noriko Ishida^§, Taichi Hara^§, Takumi Kamura^§, Minoru Yoshida^¶, Keiko Nakayama^§, and Keiichi I. Nakayama^§**

From the Departments of  Molecular and Cellular Biology and  Molecular Genetics, Medical Institute of Bioregulation, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, Fukuoka 812-8582, Japan, ^§ Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Corporation, 4-1-8 Honcho, Kawaguchi, Saitama 332-0012, Japan, and the ^¶ Department of Biotechnology, Graduate School of Agriculture and Life Sciences, University of Tokyo, Yayoi 1-1-1, Bunkyo-ku, Tokyo 113-8657, Japan

Received for publication, December 26, 2001, and in revised form, March 8, 2002

	ABSTRACT

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS AND DISCUSSION REFERENCES

Phosphorylation of the cyclin-dependent kinase inhibitor p27^Kip1 has been thought to regulate its stability. Ser¹⁰ is the major phosphorylation site of p27^Kip1, and phosphorylation of this residue affects protein stability. Phosphorylation of p27^Kip1 on Ser¹⁰ has now been shown to be required for the binding of CRM1, a carrier protein for nuclear export. The p27^Kip1 protein was translocated from the nucleus to the cytoplasm at the G₀-G₁ transition of the cell cycle, and this export was inhibited by leptomycin B, a specific inhibitor of CRM1-dependent nuclear export. The nuclear export and subsequent degradation of p27^Kip1 at the G₀-G₁ transition were observed in cells lacking Skp2, the F-box protein component of an SCF ubiquitin ligase complex, indicating that these early events are independent of Skp2-mediated proteolysis. Substitution of Ser¹⁰ with Ala (S10A) markedly reduced the extent of p27^Kip1 export, whereas substitution of Ser¹⁰ with Asp (S10D) or Glu (S10E) promoted export. Co-immunoprecipitation analysis showed that CRM1 preferentially interacted with S10D and S10E but not with S10A, suggesting that the phosphorylation of p27^Kip1 on Ser¹⁰ is required for its binding to CRM1 and for its subsequent nuclear export.

	INTRODUCTION

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS AND DISCUSSION REFERENCES

The cell cycle of eukaryotic cells is regulated by a series of protein complexes composed of cyclins and cyclin-dependent kinases (CDKs)¹ (1), the activity of which is suppressed by a group of CDK inhibitors (CKIs) (1, 2). Among the CKIs, p27^Kip1 plays a pivotal role in the control of cell proliferation (3-7). The amount of p27^Kip1 is high during the G₀ phase of the cell cycle in normal cells, but it rapidly decreases on reentry of cells into G₁ phase (8, 9). We and others have shown that mice homozygous for deletion of the p27^Kip1 gene are larger than normal mice and that they exhibit multiple organ hyperplasia as well as a predisposition to cancer (10-13). These observations support the notion that p27^Kip1 is a key determinant of both body size and the size of organs as a result of its role in the control of cell proliferation and that the loss of p27^Kip1 function may lead to carcinogenesis. Indeed many studies have shown that the expression of p27^Kip1 is deregulated in various human cancers (for review, see Ref. 14).

The function of p27^Kip1 is regulated by changes in its concentration as well as in its localization in the cell. The concentration of p27^Kip1 is thought to be controlled predominantly by the ubiquitin-proteasome pathway (15). Degradation of p27^Kip1 is promoted by its phosphorylation on Thr¹⁸⁷ by the cyclin E-CDK2 complex (16, 17), and the phosphorylation of this residue is required for the binding of p27^Kip1 to Skp2, an F-box protein that is thought to function as the receptor component of an SCF ubiquitin ligase complex; such binding then results in the ubiquitination and degradation of p27^Kip1 (18-22). We have recently shown that the degradation of p27^Kip1 at the G₀-G₁ transition is independent of Skp2 and occurs in the cytoplasm, whereas the Skp2- and Thr¹⁸⁷ phosphorylation-dependent degradation of p27^Kip1 occurs in the nucleus (23). These observations suggest that the nuclear export of p27^Kip1 may be critical for its down-regulation early during reentry of quiescent cells into the cell cycle. Consistent with this notion, Jab1 promotes the translocation of p27^Kip1 from the nucleus to the cytoplasm, decreasing the amount of p27^Kip1 in the cell by accelerating its degradation (24).

We previously identified Ser¹⁰ as a major phosphorylation site of p27^Kip1, accounting for ~70% of the total phosphorylation of this protein, and the extent of phosphorylation at this site was 75-fold greater than that at Thr¹⁸⁷ (25). The extent of Ser¹⁰ phosphorylation was markedly increased in cells in the G₀-G₁ phase of the cell cycle compared with that apparent for cells in S or M phase. Mutation analysis revealed that phosphorylation of Ser¹⁰, like that of Thr¹⁸⁷, contributes to regulation of p27^Kip1 stability. We now show that Ser¹⁰ phosphorylation is required for the binding of p27^Kip1 to CRM1, a carrier protein for nuclear export, and that the substitution of Ser¹⁰ with other residues affects the nuclear export of p27^Kip1. Our data suggest that Ser¹⁰ phosphorylation is a key event in regulation of the function of p27^Kip1 at the G₀-G₁ transition.

	EXPERIMENTAL PROCEDURES

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS AND DISCUSSION REFERENCES

Cell Culture and Synchronization-- Mouse embryonic fibroblasts (MEFs) were prepared from 13.5-day-postcoitum Skp2^+/+ and Skp2^/ embryos as described previously (26). Only nonsenescent MEFs (no more than passage 2) were used for experiments. MEFs as well as NIH 3T3 and HEK293T cells were cultured as described previously (10, 25). For analysis of synchronized cells, NIH 3T3 cells or MEFs were arrested at G₀ phase by subjecting them to serum deprivation with medium supplemented with 0.1% calf serum or fetal bovine serum, respectively, for 96 h; they were then cultured for the indicated times in medium containing 20% serum. Treatment with leptomycin B and MG132 was performed for the indicated times at concentrations of 5 ng/ml and 10 µM, respectively.

Construction of Expression Plasmids-- Complementary DNAs encoding all human p27^Kip1 derivatives (wild type, S10A, S10D, S10E, and T187A) tagged with the FLAG epitope were subcloned into pcDNA3 (Invitrogen) for transfection experiments (25) or into pRevTRE (CLONTECH) for the generation of stable inducible cell lines. For the expression of CRM1-enhanced green fluorescent protein (EGFP) fusion protein, human CRM1 cDNA was subcloned in pEGFP-N1 vector (CLONTECH).

Transfection, Immunoprecipitation, and Immunoblot Analysis-- Transfection, immunoprecipitation, and immunoblot analysis were performed as described previously with some modifications (27). For analysis of the interaction between endogenous p27^Kip1 and CRM1, lysis and washing buffers were supplemented with 2 or 0.5 µM okadaic acid, respectively. Immunoprecipitation was performed with antibodies to Myc (9E10, Roche Molecular Biochemicals), to p27^Kip1 (C-19, Santa Cruz Biotechnology), or to the FLAG epitope (M5, Sigma). Immunoblots were probed with antibodies (1 µg/ml) to the FLAG epitope (M2, Sigma), to p27^Kip1 (57, Transduction Laboratories), to lamin B1 (L-5, Zymed Laboratories Inc.), to Skp2 (Zymed Laboratories Inc.), to cyclin A (Santa Cruz Biotechnology), to cyclin D₂ (Santa Cruz Biotechnology), to CRM1 (17, Transduction Laboratories), to Jab1 (42, Transduction Laboratories), to GFP (CLONTECH), or to -tubulin (TU01, Zymed Laboratories Inc.). Two-dimensional electrophoresis was performed as described previously (25).

Doxycycline (Dox)-regulated Retroviral Expression of p27^Kip1-- NIH 3T3 cells were cotransfected with the reverse tetracycline (tet)-responsive transcriptional activator construct (pTet-On, CLONTECH) and the tet-controlled transcriptional silencer construct (pTet-tTS, CLONTECH). A clone showing high level induction by Dox was used for the expression of tet-regulated constructs delivered as retroviral particles. The pRevTRE constructs encoding p27^Kip1 derivatives were introduced by transfection into the packaging cell line PT67 (CLONTECH) for generation of retroviral particles. The supernatant of the transfected PT67 cells was used to infect the selected NIH 3T3 cell line in the presence of Polybrene (Sigma) at a concentration of 4 µg/ml. Representative clones were selected from the infected NIH 3T3 cells on the basis of the level of Dox-induced protein expression as determined by immunoblot analysis.

Immunofluorescence Analysis of p27^Kip1 Expression-- NIH 3T3 cells and MEFs were grown on glass coverslips, and immunofluorescence staining was performed as described previously (27). Endogenous and exogenous p27^Kip1 was stained with a monoclonal antibody to p27^Kip1 (57, Transduction Laboratories) and antibodies to the FLAG epitope (M5, Sigma), respectively, and immune complexes were detected with Alexa488-conjugated goat antibodies to mouse immunoglobulin G (green; Molecular Probes). Nuclei were stained with Hoechst 33258 dye (blue).

Subcellular Fractionation-- NIH 3T3 cells were lysed in an ice-cold solution containing 0.02% digitonin, 5 mM sodium phosphate (pH 7.4), 50 mM NaCl, 150 mM sucrose, 5 mM KCl, 2 mM dithiothreitol, 1 mM MgCl₂, 0.5 mM CaCl₂, and 0.1 mM phenylmethylsulfonyl fluoride. The cytoplasmic fraction was collected after centrifugation of lysates at 1000 × g for 10 min at 4 °C. The resulting pellet was resuspended in the lysis solution without digitonin and loaded onto a cushion of a solution containing 30% (w/v) sucrose, 2.5 mM Tris-HCl (pH 7.4), and 10 mM NaCl. After centrifugation at 1000 × g for 10 min at 4 °C, nuclei were collected and extracted for 30 min at 4 °C with an ice-cold solution containing 0.5% Triton X-100, 50 mM Tris-HCl (pH 7.5), and 300 mM NaCl. After centrifugation of the extract at 10,000 × g for 10 min at 4 °C, the supernatant was collected as the nuclear fraction.

	RESULTS AND DISCUSSION

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS AND DISCUSSION REFERENCES

Nuclear Export of p27^Kip1 Is Sensitive to Leptomycin B-- NIH 3T3 cells begin to enter S phase synchronously 12 h after release from serum deprivation for 96 h (data not shown). The nuclear export of p27^Kip1 was examined by immunostaining of the endogenous protein in such synchronized NIH 3T3 cells (Fig. 1A). Whereas p27^Kip1 accumulated predominantly in the nucleus of cells arrested in G₀ phase, most of the endogenous protein had translocated to the cytoplasm by 7 h after release from G₀ arrest. The p27^Kip1 signal gradually decreased thereafter and was not detected 14 h after the onset of serum stimulation (early S phase). Similar results were obtained when the nuclear export of p27^Kip1 was monitored by immunoblot analysis of nuclear and cytoplasmic fractions of the cells (Fig. 1B). The amount of p27^Kip1 in the nuclear fraction thus gradually decreased, whereas that in the cytoplasmic fraction was transiently increased at 7-10.5 h after the onset of serum stimulation. Given that the expression of Skp2 was not detected until 10.5 h after the onset of stimulation and that Skp2 is localized predominantly to the nucleus (28), Skp2 likely does not contribute to the translocation and degradation of p27^Kip1 during this time period. Treatment of cells with leptomycin B, a specific inhibitor of CRM1-dependent nuclear export (29), blocked the translocation of p27^Kip1 but did not prevent the decrease in the abundance of this protein (Fig. 1A), suggesting that the nuclear export of p27^Kip1 is not required for its degradation. Furthermore, the addition of MG132, a rapid-acting inhibitor of the proteasome, to the culture medium together with leptomycin B inhibited the degradation of p27^Kip1 in the nucleus. These data suggest the existence of two independent pathways for p27^Kip1 proteolysis, one in the nucleus and one in the cytoplasm.

View larger version (28K): [in this window] [in a new window]   Fig. 1.   Cell cycle-dependent nuclear export of p27Kip1. A, NIH 3T3 cells synchronized at G0 phase of the cell cycle by serum deprivation were restimulated to enter the cell cycle by exposure to 20% serum for the indicated times in the absence (Mock) or presence of leptomycin B (LMB) at 5 ng/ml or of both leptomycin B and 10 µM MG132. Cells were subjected to immunostaining for endogenous p27Kip1 (upper panels of each set), and the resulting images were superimposed with those obtained by staining nuclei with Hoechst 33258 (lower panels). B, NIH 3T3 cells were arrested at G0 and restimulated with serum as in A, and at the indicated times, they were subjected to subcellular fractionation. Nuclear and cytoplasmic fractions (25 µg of protein) as well as whole cell lysates (30 µg of protein) were subjected to immunoblot analysis with antibodies specific for the indicated proteins. C, NIH 3T3 cells were synchronized and subjected to subcellular fractionation as in B. The amount of lysate protein analyzed for two-dimensional electrophoresis was varied from 100 to 500 µg to ensure that the amounts of endogenous p27Kip1 were similar at the different times of G0-G1 transition. The positions corresponding to unphosphorylated and phosphorylated p27Kip1 are indicated as are the amounts of each of these two forms of the protein expressed as a percentage of total p27Kip1. pp27, phospho-p27; NEPHGE, nonequilibrium pH gradient electrophoresis.

Our previous report demonstrated that the extent of Ser¹⁰ phosphorylation was markedly increased in cells in the G₀ phase of the cell cycle compared with that apparent for cells in S or M phase (25). We thus examined the relative amounts of two (phosphorylated versus nonphosphorylated) forms of p27^Kip1 in the nucleus versus cytoplasm (Fig. 1C). Two-dimensional electrophoresis and immunoblot analysis with anti-p27^Kip1 in the nucleus fraction of NIH 3T3 cells revealed that ~50% of endogenous p27^Kip1 was phosphorylated on Ser¹⁰ at G₀ phase, whereas the amount of this form of the protein was reduced to ~25% in late G₁ phase (8 h after the serum stimulation). In contrast, ~70% of p27^Kip1 protein was phosphorylated in the cytoplasm in the late G₁ phase. These data suggest that p27^Kip1 is phosphorylated on Ser¹⁰ in the nucleus at G₀ phase, and the phosphorylated p27^Kip1 is translocated from nucleus to cytoplasm in late G₁ phase.

Nuclear Export and Degradation of p27^Kip1 at G₀-G₁ Are Not Dependent on Skp2-- To confirm that the nuclear export and degradation of p27^Kip1 at the G₀-G₁ transition are not dependent on Skp2-mediated proteolysis, we studied wild-type and Skp2^/ MEFs. MEFs begin to enter S phase synchronously 16 h after release from serum deprivation for 96 h (data not shown). Immunofluorescence analysis revealed that p27^Kip1 was translocated from the nucleus to the cytoplasm and degraded in Skp2^/ MEFs as well as in Skp2^+/+ MEFs (Fig. 2A); however, as we previously demonstrated in Skp2^/ lymphocytes (23), p27^Kip1 began to reaccumulate in the nucleus of Skp2^/ MEFs during S phase. Immunoblot analysis of whole cell lysates confirmed that the decrease in p27^Kip1 abundance at the G₀-G₁ transition does not require Skp2 (Fig. 2B). These data indicate that the nuclear export and degradation of p27^Kip1 at the G₀-G₁ transition are not dependent on Skp2.

View larger version (31K): [in this window] [in a new window]   Fig. 2.   Skp2-independent translocation of p27Kip1. A, Skp2+/+ and Skp2/ MEFs synchronized at G0 phase by serum deprivation for 96 h were restimulated to enter the cell cycle by exposure to 20% serum for the indicated times. Cells were then subjected to immunostaining for endogenous p27Kip1 (upper panels of each set), and the resulting images were superimposed with those of nuclear staining with Hoechst 33258 (lower panels). B, Skp2+/+ and Skp2/ MEFs synchronized at G0 phase were restimulated with serum as in A. Whole cell lysates (30 µg of protein) were then subjected to immunoblot analysis with antibodies to p27Kip1, to cyclin A, or to -tubulin.

CRM1 Interacts with p27^Kip1 in a Ser¹⁰ Phosphorylation-dependent Manner-- Given that CRM1 is implicated in the nuclear export of many proteins (30) and that the nuclear export of p27^Kip1 at the G₀-G₁ transition was inhibited by leptomycin B, we examined whether CRM1 interacts with p27^Kip1. Immunoblot analysis revealed that endogenous CRM1 was specifically present in immunoprecipitates prepared from NIH 3T3 cells with antibodies to p27^Kip1 (Fig. 3A). Endogenous Jab1 was not detected in these immunoprecipitates, suggesting that Jab1-mediated export of p27^Kip1 is accomplished by a distinct mechanism. Given that p27^Kip1 phosphorylated on Ser¹⁰ seems to be efficiently translocated from nucleus to cytoplasm in late G₁ phase (Fig. 1C), we next investigated the interaction between recombinant CRM1 and p27^Kip1 derivatives co-expressed in HEK293T cells (Fig. 3B). Co-immunoprecipitation analysis revealed that the substitution of Ser¹⁰ of p27^Kip1 with the acidic residues Asp (S10D) or Glu (S10E) markedly enhanced the interaction between CRM1 and p27^Kip1, whereas replacement of Ser¹⁰ with Ala (S10A) reduced the extent of binding. Mutation of Thr¹⁸⁷ of p27^Kip1 to Ala did not affect the association with CRM1.

View larger version (28K): [in this window] [in a new window]   Fig. 3.   Ser10 phosphorylation-dependent interaction of p27Kip1 with CRM1. A, NIH 3T3 cells synchronized at G0 phase of the cell cycle by serum deprivation for 96 h were restimulated to enter the cell cycle by exposure to 20% serum for 4 h. Whole cell lysates (0.4 mg of protein) were then subjected to immunoprecipitation (IP) with antibodies to p27Kip1 or to Myc (control), and the resulting precipitates were subjected to immunoblot analysis with antibodies to CRM1, to Jab1, or to p27Kip1. A portion (10%) of the input lysates was also subjected directly to immunoblot analysis with the same antibodies. IgL, immunoglobulin light chain. B, HEK293T cells were cotransfected with vectors encoding an EGFP-CRM1 fusion protein and either FLAG-tagged wild-type (WT) p27Kip1 or its S10D, S10E, S10A, or T187A mutants. Cell lysates (0.5 mg of protein) were then subjected to immunoprecipitation with antibodies to the FLAG epitope, and the resulting precipitates were subjected to immunoblot (IB) analysis with antibodies to GFP or to p27Kip1. A portion (10%) of the input lysates was also subjected directly to immunoblot analysis with the same antibodies.

Finally we examined the ability of the various p27^Kip1 derivatives to undergo translocation from the nucleus to the cytoplasm. Wild-type and mutant derivatives of p27^Kip1 were expressed in NIH 3T3 cells with the use of the retroviral Dox-regulated system. The expression of the p27^Kip1 derivatives was induced by Dox during serum deprivation for 96 h and was then terminated by removal of Dox from the medium at which time serum was added back to the medium to induce the translocation of p27^Kip1. Immunofluorescence analysis revealed that wild-type, S10D, and S10A derivatives of p27^Kip1 were located in the nucleus in the absence of serum stimulation (Fig. 4A), suggesting that Ser¹⁰ phosphorylation is not sufficient for nuclear export. This notion is consistent with our previous observation that p27^Kip1 is located in the nucleus of quiescent cells even though Ser¹⁰ is highly phosphorylated (25). The stimulation-induced translocation of the S10A mutant of p27^Kip1 was markedly inhibited compared with that observed with the wild-type and S10D proteins. Quantitative analysis indicated that the efficiency of export was greater for the S10D mutant than for wild-type p27^Kip1 (Fig. 4B). The amount of the S10A mutant remaining in the nucleus was markedly greater than that apparent for wild-type p27^Kip1 (Fig. 4, A and B). The observations that the translocation of the S10A mutant was not affected by leptomycin B (data not shown) and that the amount of this protein in the nucleus of stimulated cells never achieved the level apparent in quiescent cells (Fig. 4B) suggest that a fraction of p27^Kip1 is exported from the nucleus by a mechanism independent of CRM1 and Ser¹⁰ phosphorylation. These results indicate that phosphorylation of Ser¹⁰ of p27^Kip1 is required for the binding of CRM1 and subsequent translocation of p27^Kip1 to the cytoplasm. However, the phosphorylation is not sufficient for the nuclear export, and another factor(s) may be necessary in addition to the phosphorylation of Ser¹⁰.

View larger version (15K): [in this window] [in a new window]   Fig. 4.   Ser10 phosphorylation-dependent nuclear export of p27Kip1. A, expression of Tet-On FLAG-p27Kip1 derivatives was induced by Dox (1 µg/ml) during synchronization of NIH 3T3 cells at G0 phase by serum deprivation for 96 h (upper panels). The cells were then restimulated to enter the cell cycle by exposure to 20% serum in Dox-free medium (lower panels) for 8 h. The subcellular localization of recombinant p27Kip1 was determined by immunofluorescence staining with antibodies to the FLAG epitope, and the nuclei of the same cells were revealed by staining with Hoechst 33258. B, quantitative analysis of the subcellular localization of p27Kip1 derivatives in experiments similar to that described in A. At least 300 cells were scored for each sample. Data represent the percentage of cells showing predominant localization of p27Kip1 in the nucleus and are means ± S.E. of values from three independent experiments. WT, wild type.

Nuclear Export Controlled by Ser¹⁰ Phosphorylation Is Important for p27^Kip1 Down-regulation at the G₀-G₁ Transition-- We have recently shown that the ubiquitin-mediated proteolysis of p27^Kip1 at the G₀-G₁ transition occurs normally in Skp2^/ cells (23), whereas the degradation of this protein during S and G₂ phases is markedly impaired in these cells. Given also that Skp2 is not expressed in the early phase (G₀-G₁) of p27^Kip1 degradation, this process appears to be independent of Skp2. In contrast, our previous data indicate that Skp2 is indispensable for the late phase (S-G₂) of p27^Kip1 degradation (23). The Skp2- and Thr¹⁸⁷ phosphorylation-dependent degradation of p27^Kip1 occurs in the nucleus, whereas the proteolysis independent of Skp2 and Thr¹⁸⁷ phosphorylation appears to occur in the cytoplasm. In vitro ubiquitination assays revealed that the polyubiquitination activity in the cytoplasm appears to be active throughout the cell cycle and that the substitution of Ser¹⁰ with Asp, Glu, or Ala does not affect the p27^Kip1 polyubiquitination.² These data suggest that the phosphorylation of Ser¹⁰ is important for the regulation of p27^Kip1 translocation but not for degradation itself; p27^Kip1 may be polyubiquitinated by the constitutively active ubiquitination machinery in the cytoplasm regardless of the phosphorylation status of Ser¹⁰ once the protein has been translocated to the cytoplasm. Identification of the putative proline-directed kinase responsible for the phosphorylation of p27^Kip1 on Ser¹⁰ as well as of the upstream signaling pathways that link to this kinase should provide further insight into the mechanism of the early phase of degradation of this CKI, which is required for the G₀-G₁ transition.

During preparation of this manuscript, Rodier et al. (31) also reported that phosphorylation on Ser¹⁰ is necessary for the nuclear export of p27^Kip1. Although our present results are mostly consistent with those of Rodier et al., these latter researchers demonstrated that endogenous p27^Kip1 phosphorylated on Ser¹⁰ is translocated from nucleus into cytoplasm by using the antibody that is specific for p27^Kip1 phosphorylated on Ser¹⁰. We added the finding that p27^Kip1 physically associates with the carrier protein CRM1 and that the formation of this complex is controlled by the phosphorylation of p27^Kip1 on Ser¹⁰. Both reports suggest that the nuclear export of p27^Kip1 is regulated by the phosphorylation on Ser¹⁰ and plays a critical role to decrease the abundance of p27^Kip1 protein below a certain threshold to allow the activation of cyclin-CDK complexes.

	ACKNOWLEDGEMENTS

We thank S. Hatakeyama and M. Kitagawa for helpful discussion; K. Shimoharada, R. Yasukochi, N. Nishimura, and S. Matsushita for technical assistance; and M. Kimura for help in preparation of the manuscript.

	FOOTNOTES

^* This work was supported in part by a research grant from the Human Frontier Science Program.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

^** To whom correspondence should be addressed: Dept. of Molecular and Cellular Biology, Medical Inst. of Bioregulation, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, Fukuoka 812-8582, Japan. Tel.: 81-92-642-6815; Fax: 81-92-642-6819; E-mail: nakayak1@bioreg. kyushu-u.ac.jp.

Published, JBC Papers in Press, March 11, 2002, DOI 10.1074/jbc.C100762200

² T. Kamura, and K. I. Nakayama, manuscript in preparation.

	ABBREVIATIONS

The abbreviations used are: CDK, cyclin-dependent kinase; CKI, CDK inhibitor; MEF, mouse embryonic fibroblast; GFP, green fluorescent protein; EGFP, enhanced GFP; Dox, doxycycline; tet, tetracycline; SCF, Skp1-Cullin-1/Cdc53-F-box protein.

	REFERENCES

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS AND DISCUSSION REFERENCES

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				G. A. Miranda-Carboni, S. A. Krum, K. Yee, M. Nava, Q. E. Deng, S. Pervin, A. Collado-Hidalgo, Z. Galic, J. A. Zack, K. Nakayama, et al. A functional link between Wnt signaling and SKP2-independent p27 turnover in mammary tumors Genes & Dev., November 15, 2008; 22(22): 3121 - 3134. [Abstract] [Full Text] [PDF]

				D. Morishita, R. Katayama, K. Sekimizu, T. Tsuruo, and N. Fujita Pim Kinases Promote Cell Cycle Progression by Phosphorylating and Down-regulating p27Kip1 at the Transcriptional and Posttranscriptional Levels Cancer Res., July 1, 2008; 68(13): 5076 - 5085. [Abstract] [Full Text] [PDF]

				K. Sakurai and N. Osumi The Neurogenesis-Controlling Factor, Pax6, Inhibits Proliferation and Promotes Maturation in Murine Astrocytes J. Neurosci., April 30, 2008; 28(18): 4604 - 4612. [Abstract] [Full Text] [PDF]

				J. Chen, E. Guerriero, K. Lathrop, and N. SundarRaj Rho/ROCK Signaling in Regulation of Corneal Epithelial Cell Cycle Progression Invest. Ophthalmol. Vis. Sci., January 1, 2008; 49(1): 175 - 183. [Abstract] [Full Text] [PDF]

				J. G. Lee and E. P. Kay Involvement of Two Distinct Ubiquitin E3 Ligase Systems for p27 Degradation in Corneal Endothelial Cells Invest. Ophthalmol. Vis. Sci., January 1, 2008; 49(1): 189 - 196. [Abstract] [Full Text] [PDF]

				M. F. Crook, M. Olive, H.-H. Xue, T. H. Langenickel, M. Boehm, W. J. Leonard, and E. G. Nabel GA-binding protein regulates KIS gene expression, cell migration, and cell cycle progression FASEB J, January 1, 2008; 22(1): 225 - 235. [Abstract] [Full Text] [PDF]

				T. Hattori, T. Isobe, K. Abe, H. Kikuchi, K. Kitagawa, T. Oda, C. Uchida, and M. Kitagawa Pirh2 Promotes Ubiquitin-Dependent Degradation of the Cyclin-Dependent Kinase Inhibitor p27Kip1 Cancer Res., November 15, 2007; 67(22): 10789 - 10795. [Abstract] [Full Text] [PDF]

				Y.-H. Ling, T. Li, Z. Yuan, M. Haigentz Jr., T. K. Weber, and R. Perez-Soler Erlotinib, an Effective Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, Induces p27KIP1 Up-Regulation and Nuclear Translocation in Association with Cell Growth Inhibition and G1/S Phase Arrest in Human Non-Small-Cell Lung Cancer Cell Lines Mol. Pharmacol., August 1, 2007; 72(2): 248 - 258. [Abstract] [Full Text] [PDF]

				E. Susaki, K. Nakayama, and K. I. Nakayama Cyclin D2 Translocates p27 out of the Nucleus and Promotes Its Degradation at the G0-G1 Transition Mol. Cell. Biol., July 1, 2007; 27(13): 4626 - 4640. [Abstract] [Full Text] [PDF]

				J. G. Lee and E. P. Kay Two Populations of p27 Use Differential Kinetics to Phosphorylate Ser-10 and Thr-187 via Phosphatidylinositol 3-Kinase in Response to Fibroblast Growth Factor-2 Stimulation J. Biol. Chem., March 2, 2007; 282(9): 6444 - 6454. [Abstract] [Full Text] [PDF]

				B. Fries, J. Heukeshoven, I. Hauber, C. Gruttner, C. Stocking, R. H. Kehlenbach, J. Hauber, and J. Chemnitz Analysis of Nucleocytoplasmic Trafficking of the HuR Ligand APRIL and Its Influence on CD83 Expression J. Biol. Chem., February 16, 2007; 282(7): 4504 - 4515. [Abstract] [Full Text] [PDF]

				A. Bernreiter, A. Ramon, J. Fernandez-Martinez, H. Berger, L. Araujo-Bazan, E. A. Espeso, R. Pachlinger, A. Gallmetzer, I. Anderl, C. Scazzocchio, et al. Nuclear Export of the Transcription Factor NirA Is a Regulatory Checkpoint for Nitrate Induction in Aspergillus nidulans Mol. Cell. Biol., February 1, 2007; 27(3): 791 - 802. [Abstract] [Full Text] [PDF]

				J. Lecanda, T. V. Parekh, P. Gama, K. Lin, V. Liarski, S. Uretsky, K. Mittal, and L. I. Gold Transforming Growth Factor-{beta}, Estrogen, and Progesterone Converge on the Regulation of p27Kip1 in the Normal and Malignant Endometrium Cancer Res., February 1, 2007; 67(3): 1007 - 1018. [Abstract] [Full Text] [PDF]

				Z. Li, X. Jiao, C. Wang, X. Ju, Y. Lu, L. Yuan, M. P. Lisanti, S. Katiyar, and R. G. Pestell Cyclin D1 Induction of Cellular Migration Requires p27KIP1. Cancer Res., October 15, 2006; 66(20): 9986 - 9994. [Abstract] [Full Text] [PDF]

				M. J. Jakoby, C. Weinl, S. Pusch, S. J.H. Kuijt, T. Merkle, N. Dissmeyer, and A. Schnittger Analysis of the Subcellular Localization, Function, and Proteolytic Control of the Arabidopsis Cyclin-Dependent Kinase Inhibitor ICK1/KRP1 Plant Physiology, August 1, 2006; 141(4): 1293 - 1305. [Abstract] [Full Text] [PDF]

				M. L. Gatza and S. J. Marriott Genotoxic Stress and Cellular Stress Alter the Subcellular Distribution of Human T-Cell Leukemia Virus Type 1 Tax through a CRM1-Dependent Mechanism. J. Virol., July 1, 2006; 80(13): 6657 - 6668. [Abstract] [Full Text] [PDF]

				L. Bockstaele, H. Kooken, F. Libert, S. Paternot, J. E. Dumont, Y. de Launoit, P. P. Roger, and K. Coulonval Regulated Activating Thr172 Phosphorylation of Cyclin-Dependent Kinase 4(CDK4): Its Relationship with Cyclins and CDK "Inhibitors". Mol. Cell. Biol., July 1, 2006; 26(13): 5070 - 5085. [Abstract] [Full Text] [PDF]

				A. Parcellier, M. Brunet, E. Schmitt, E. Col, C. Didelot, A. Hammann, K. Nakayama, K. I. Nakayama, S. Khochbin, E. Solary, et al. HSP27 favors ubiquitination and proteasomal degradation of p27Kip1 and helps S-phase re-entry in stressed cells FASEB J, June 1, 2006; 20(8): 1179 - 1181. [Abstract] [Full Text] [PDF]

				A. Borriello, V. Cucciolla, M. Criscuolo, S. Indaco, A. Oliva, A. Giovane, D. Bencivenga, A. Iolascon, V. Zappia, and F. Della Ragione Retinoic Acid Induces p27Kip1 Nuclear Accumulation by Modulating Its Phosphorylation. Cancer Res., April 15, 2006; 66(8): 4240 - 4248. [Abstract] [Full Text] [PDF]

				T. Bondar, A. Kalinina, L. Khair, D. Kopanja, A. Nag, S. Bagchi, and P. Raychaudhuri Cul4A and DDB1 Associate with Skp2 To Target p27Kip1 for Proteolysis Involving the COP9 Signalosome. Mol. Cell. Biol., April 1, 2006; 26(7): 2531 - 2539. [Abstract] [Full Text] [PDF]

				K. Tabu, A. Ohnishi, Y. Sunden, T. Suzuki, M. Tsuda, S. Tanaka, T. Sakai, K. Nagashima, and H. Sawa A novel function of OLIG2 to suppress human glial tumor cell growth via p27Kip1 transactivation. J. Cell Sci., April 1, 2006; 119(Pt 7): 1433 - 1441. [Abstract] [Full Text] [PDF]